Hepatopulmonary syndrome is associated with low sphingosine-1-phosphate levels and can be ameliorated by the functional agonist fingolimod-Reference-Cited by-同舟云学术

Hepatopulmonary syndrome is associated with low sphingosine-1-phosphate levels and can be ameliorated by the functional agonist fingolimod

Published:2023-07 Issue:1 Volume:79 Page:167-180
ISSN:0168-8278
Container-title:Journal of Hepatology
language:en
Short-container-title:Journal of Hepatology

Author:

Baweja Sukriti,Kumari Anupama,Negi Preeti,Tomar Arvind,Tripathi Dinesh Mani,Mourya Akash Kumar,Rastogi Aayushi^ORCID,Subudhi P. Debishree,Thangariyal Swati,Kumar Guresh,Kumar Jitendra,Reddy G. Srinivasa,Sood Arun Kumar,Vashistha Chitranshu,Sarohi Vivek^ORCID,Bihari Chhagan,Maiwall Rakhi,Sarin Shiv Kumar^ORCID

Funder

Science and Engineering Research Board

Publisher

Elsevier BV

Subject

Hepatology

Reference36 articles.

1. Hepatopulmonary syndrome—a liver-induced lung vascular disorder;Rodríguez-Roisin;N Engl J Med,2008

2. Pulmonary dysfunction in chronic liver disease;Fallon;Hepatology,2000

3. Diagnosis of hepatopulmonary syndrome in a large integrated health system;Bommena;Clin Gastroenterol Hepatol,2021

4. Hepatopulmonary syndrome and portopulmonary hypertension: implications for liver transplantation;Krowka;Clin Chest Med,2005

5. Prospective evaluation of outcomes and predictors of mortality in patients with hepatopulmonary syndrome undergoing liver transplantation;Arguedas;Hepatology,2003

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dysregulation of sphingolipid metabolism in liver fibrosis;Metabolism and Target Organ Damage;2024-09-14

2. Exogenous S1P via S1P receptor 2 induces CTGF expression through Src-RhoA-ROCK-YAP pathway in hepatic stellate cells;Molecular Biology Reports;2024-09-02

3. MPO Mediated Precise Inflammation Targeting of Antioxidant Melanin Nanomedicines as an Effective Therapeutic Strategy for Chronic Inflammation;2024-08-02

4. Fingolimod as a sphingolipid modulator in hepatopulmonary syndrome: A critical review;Journal of Hepatology;2023-11

5. Fingolimod, a sphingosine-1-phosphate agonist for the treatment of hepatopulmonary syndrome: Queries and concerns;Journal of Hepatology;2023-11